Income Statement (TTM)
AEON Biopharma, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
|
|---|---|---|---|---|
| Revenue | 3 | 2 | 1 | 1 |
| Change (%) | -29.27 | -36.72 | -50.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Gross Operating Profit | 3 | 2 | 1 | 1 |
| Change (%) | -29.27 | -36.72 | -50.00 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 12 | 11 | 11 | 10 |
| Change (%) | -5.02 | -3.09 | -5.49 | |
| % of Revenue | 460.17 | 617.91 | 946.32 | 1,788.73 |
| R&D | 7 | 12 | 16 | 21 |
| Change (%) | 59.46 | 36.78 | 29.61 | |
| % of Revenue | 290.67 | 655.31 | 1,416.50 | 3,671.96 |
| OpEx | 19 | 23 | 27 | 31 |
| Change (%) | 19.94 | 17.43 | 15.55 | |
| % of Revenue | 750.83 | 1,273.22 | 2,362.82 | 5,460.69 |
| Operating Income | -16 | -21 | -26 | -30 |
| Change (%) | 27.50 | 22.05 | 18.45 | |
| % of Revenue | -650.83 | -1,173.22 | -2,262.82 | -5,360.69 |
| Interest Expense | -0 | -0 | -0 | -0 |
| Change (%) | -93.33 | -0.00 | -50.00 | |
| % of Revenue | -0.60 | -0.06 | -0.09 | -0.09 |
| Net Income | -33 | -16 | -53 | -57 |
| Change (%) | -50.67 | 228.92 | 7.62 | |
| % of Revenue | -1,307.11 | -911.68 | -4,738.86 | -10,200.35 |
Source: Capital IQ
